San Diego, California 92130
Jerry Swiss is a partner and intellectual property lawyer with Foley & Lardner LLP. He concentrates his practice on strategic counseling, including implementation of IP strategy for clients in the biopharmaceutical, life science and medical device arenas. Mr. Swiss has approximately 30 years of IP experience in patent prosecution directed to protecting small molecules, chemical processes, enzymes, and medical devices. In particular, he has handled a significant amount of IP work on new chemical entity scaffolds for the treatment of cancers, anemia, thrombosis, and inflammatory diseases. He is a member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.
In addition to his patent prosecution skills, Mr. Swiss’ legal experience includes developing international patent strategies for critical lead compounds and new discovery platforms, addressing due diligence, freedom to operate, validity and infringement/non-infringement analyses, as well as patent procurement.
Mr. Swiss started his career as a medicinal research chemist at Schering Corporation, where he worked in the synthesis of small molecules in the pharmaceutical arena. His research focused on anti-inflammatory and anti-hypertensive compounds.
|Areas of Practice||1) Chemical, 2) Biotechnology & Pharmaceutical and 3) Green Energy Technologies|
|Law School||Seton Hall University School of Law|
|Education||University of Notre Dame (B.S.) the University of Chicago (M.S.)|
|Bar Member / Association||State Bar Of California , State Bar Of New Jersey|
|Most recent firm||Foley & Lardner LLP|
Andrew Hamilton is a partner in Morgan Lewis's Business and Finance Practice. Mr. Hamilton practices in the areas of mergers and acquisitions, private equity and venture capital, securities law, and general corporate counseling.
Anthony C. DeCusatis is of counsel in Morgan Lewis's Energy Practice.He also represents and counsels utilities and nonutility energy suppliers on emerging issues created by the transition from regulation to competitive markets.